BioSpace News Archive

Reflection Biotechnologies Limited today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to ReflectionBio’s RBIO-101 program

The fund will continue its current strategy of investing in growth-oriented, middle-market healthcare companies.

LINE-X Aims to Top $103,000 Raised Last Year; Campaign Runs from August 27 to September 30 Throughout North America [28-August-2018] HUNTSVILLE, Ala., Aug. 28, 2018 /PRNewswire/ -- LINE-X - a global leader in powerful protective coatings, renowned spray-on bedliners and first-rate truck accessories - kicks off its second-annual partnership with St. Jude Ch

Physician-led clinical integration network and ACO partners with NextGate for accurate, timely and complete provider data across the continuum

LLS is leading the way to cancer cures, during Blood Cancer Awareness Month and beyond

Medicenna Therapeutics Corp. a clinical stage immuno-oncology company, is pleased to announce that preclinical data on its IL-2 Superkine, MDNA109

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection

GT Biopharma Inc. announced today the initiation of a combination trial of OXS-1550 and multi-billion dollar oncology drug, owned by a major Pharmaceutical Company (the Company).

YGYI, Inc. (YGYI), a leading omni-direct lifestyle company, launched several highly anticipated new products at their 2018 Convention in San Diego, California, between Aug. 23 and 25.

[28-August-2018] DALLAS, Aug. 28, 2018 /PRNewswire/ -- NexPoint Capital, Inc. (the “Company”), a non-traded publicly registered business development company and affiliate of Highland Capital Management, L.P., today announced that it will commence a voluntary tender offer on or about August 28, 2018 (the “Tender Offer”) for up to 2.5% of its outstanding common stock (“